Authors:
Burren, CP
Woods, KA
Rose, SJ
Tauber, M
Price, DA
Heinrich, U
Gilli, G
Razzaghy-Azar, M
Al-Ashwal, A
Crock, PA
Rochiccioli, P
Yordam, N
Ranke, MB
Chatelain, PG
Preece, MA
Rosenfeld, RG
Savage, MO
Citation: Cp. Burren et al., Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome, HORMONE RES, 55(3), 2001, pp. 125-130
Authors:
Savage, MO
Lienhardt, A
Lebrethon, MC
Johnston, LB
Huebner, A
Grossman, AB
Afshar, F
Plowman, PN
Besser, GM
Citation: Mo. Savage et al., Cushing's disease in childhood: presentation, investigation, treatment andlong-term outcome, HORMONE RES, 55, 2001, pp. 24-30
Authors:
MacFarlane, CE
Brown, DC
Johnston, LB
Patton, MA
Dunger, DB
Savage, MO
McKenna, WJ
Kelnar, CJH
Citation: Ce. Macfarlane et al., Growth hormone therapy and growth in children with Noonan's syndrome: Results of 3 years' follow-up, J CLIN END, 86(5), 2001, pp. 1953-1956
Citation: Mo. Savage, The combined pituitary function test is not indicated in the routine investigation of short stature, CLIN ENDOCR, 52(6), 2000, pp. 679-679
Authors:
Johnston, LB
Pashankar, F
Camacho-Hubner, C
Savage, MO
Clark, AJL
Citation: Lb. Johnston et al., Analysis of the intracellular signalling domain of the human growth hormone receptor in children with idiopathic short stature, CLIN ENDOCR, 52(4), 2000, pp. 463-469
Authors:
Lebrethon, MC
Grossman, AB
Afshar, F
Plowman, PN
Besser, GM
Savage, MO
Citation: Mc. Lebrethon et al., Linear growth and final height after treatment for Cushing's disease in childhood, J CLIN END, 85(9), 2000, pp. 3262-3265
Authors:
Woods, KA
Camacho-Hubner, C
Bergman, RN
Barter, D
Clark, AJL
Savage, MO
Citation: Ka. Woods et al., Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion, J CLIN END, 85(4), 2000, pp. 1407-1411
Authors:
Camacho-Hubner, C
Woods, KA
Miraki-Moud, F
Clark, A
Savage, MO
Citation: C. Camacho-hubner et al., Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: Effects of rhIGF-I therapy, GROWTH H I, 9, 1999, pp. 47-51
Authors:
Goddard, AG
Harris, SJ
Plowman, PN
Savage, MO
Kingston, JE
Citation: Ag. Goddard et al., Growth hormone deficiency following radiotherapy for orbital and parameningeal sarcomas, PED HEM ONC, 16(1), 1999, pp. 23-33
Authors:
Ranke, MB
Savage, MO
Chatelain, P
Preece, MA
Rosenfeld, RG
Wilton, P
Citation: Mb. Ranke et al., Treatment of growth hormone insensitivity syndrome with insulin-like growth factor I: long-term results of the European multicentre study, ACT PAEDIAT, 88, 1999, pp. 180-180
Authors:
Azcona, C
Preece, MA
Rose, SJ
Fraser, N
Rappaport, R
Ekelow, A
Ranke, MB
Savage, MO
Citation: C. Azcona et al., Treatment of growth hormone insensitivity syndrome with insulin-like growth factor I: relationship between growth response and severity of phenotype, ACT PAEDIAT, 88, 1999, pp. 193-193
Citation: Mb. Ranke et al., Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS), J PED END M, 12, 1999, pp. 259-266
Authors:
Ranke, MB
Savage, MO
Chatelain, PG
Preece, MA
Rosenfeld, RG
Wilton, P
Citation: Mb. Ranke et al., Long-term treatment of growth hormone insensitivity syndrome with IGF-I - Results of the European multicentre study, HORMONE RES, 51(3), 1999, pp. 128-134